CYTOLON AG has a total of 25 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and China. Its main competitors in its focus markets computer technology, it methods for management and measurement are MEDICOMP SYSTEMS INC, MOLECULAR HEALTH AG and HOFFMAN MARK A.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | China | 3 | |
#4 | Australia | 2 | |
#5 | Singapore | 2 | |
#6 | United States | 2 | |
#7 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | IT methods for management | |
#3 | Measurement | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Klein Thomas | 21 |
#2 | Schliehe-Diecks Ralf | 9 |
#3 | Schimanski Andreas | 6 |
#4 | Keller Frank | 3 |
#5 | Spierings Hendrikus Theodorus | 2 |
#6 | Dudenhausen Joachim | 1 |
#7 | Mccloskey Daniel | 1 |
#8 | Thomas Klein | 1 |
#9 | Schapranow Matthieu-Patrick | 1 |
#10 | Frank Keller | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016026934A1 | Method for selecting a transplantation donor or donor material using low or intermediate hla typing information | |
WO2015169597A1 | Methods and systems for predicting alloreactivity in transplantation | |
WO2015144931A1 | Immerse software-as-a-service patient empowerment platform for clinical trial participants | |
SG11201402403XA | Central control of distributed organizational structures | |
WO2011095365A2 | Automated system for selecting and mediating stored allogeneic biological cells for transplantation, therapy and research | |
WO2010089158A1 | Automated system for the comparison of individual genome, transcriptome, proteome, epigenome, and metabolome data with data from bonemarrow donor registers and blood banks, umbilical cord blood banks, and tissue banks | |
CN102144233A | Automated system for the selection and conveyance of stored allogeneic biological cells for transplant, therapy and research |